Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

DCLHb evaluated in critically ill patients

Oct. 13, 1997

CV Therapeutics moves ranolazine to phase III

Oct. 13, 1997

Renal effects of NO donor FK-409 in dogs

Oct. 10, 1997

BMS and ICAgen establish ion channel collaboration

Oct. 10, 1997

Hoechst discloses antiischemic agents

Oct. 10, 1997

Spotlight on angiotensin II blocker/ACE inhibitor combination therapy

Oct. 10, 1997

Mutual recognition approval obtained for Astra's angiotensin II blocker

Oct. 9, 1997

Flocor pivotal trial supported by FDA grant

Oct. 9, 1997

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Octreotide assessed in treatment of restenosis in VERAS study

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...